|
Fred Cohen MD D Phil has served as a director of Genomic Health since April 2002. In 2001 Dr. Cohen joined TPG Ventures a venture capital firm as a Managing Director. Dr. Cohen is also a Professor of Medicine and Pharmacology at the University of California San Francisco where he has taught since July 1988. Dr. Cohen is a director of Matrix Laboratories Ltd. and a number of privately held companies. Dr. Cohen holds a BS from Yale University a D Phil from Oxford University and an MD from Stanford University. | 